Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma

doi:10.3748/wjg.v16.i37.4697

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 37

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3852)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

324

HTML

3261

Figures (1-3)

152

Tables (1-5)

115

Sum=3852

Oct 7, 2010 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (43)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Oct 7, 2010; 16(37): 4697-4703
Published online Oct 7, 2010. doi: 10.3748/wjg.v16.i37.4697

Table 2 Performance of the biomarkers for the diagnosis of cholangiocarcinoma (%) (95% CI)

Tumor markers (cut-off value)	Sensitivity	Specificity	PPV	NPV	LR+	LR-
MMP7 (5.5 ng/mL)	75 (63-86)	78 (71-85)	61 (50-72)	87 (81-93)	3.41 (2.38-4.89)	0.33 (0.21-0.51)
MMP7 (6.5 ng/mL)	63 (50-75)	87 (81-93)	69 (56-81)	83 (77-90)	4.72 (2.91-7.66)	0.43 (0.31-0.60)
MMP7 (7.5 ng/mL)	53 (40-65)	92 (88-97)	76 (62-89)	81 (74-87)	6.73 (3.54-12.70)	0.51 (0.39-0.68)
CA19-9 (35 U/mL)	71 (60-83)	73 (66-81)	55 (44-66)	85 (78-91)	2.68 (1.93-3.73)	0.39 (0.26-0.59)
CA19-9 (100 U/mL)	68 (56-80)	87 (81-93)	70 (58-82)	85 (79-91)	5.1 (3.17-8.22)	0.37 (0.25-0.54)
CA19-9 (200 U/mL)	59 (47-72)	93 (89-97)	80 (68-91)	83 (77-89)	8.44 (4.34-16.40)	0.44 (0.32-0.60)

PPV: Positive predictive value; NPV: Negative predictive value; LR+: Positive likelihood ratio; LR-: Negative likelihood ratio; CI: Confidence interval; MMP7: Matrix metalloproteinase-7; CA19-9: Carbohydrate antigen 19-9.

Citation: Leelawat K, Narong S, Wannaprasert J, Ratanashu-ek T. Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma. World J Gastroenterol 2010; 16(37): 4697-4703
URL: https://www.wjgnet.com/1007-9327/full/v16/i37/4697.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i37.4697